首页> 外文期刊>Journal of Ethnopharmacology: An Interdisciplinary Journal Devoted to Bioscientific Research on Indigenous Drugs >Studies on the glycemic and lipidemic effect of Murraya koenigii in experimental animals.
【24h】

Studies on the glycemic and lipidemic effect of Murraya koenigii in experimental animals.

机译:关于实验动物Murraya koenigii的降血糖和降血脂作用的研究。

获取原文
获取原文并翻译 | 示例
           

摘要

Diabetes is often accompanied by lipid abnormalities, which contribute significantly to cardiovascular morbidity and mortality in diabetic patients. Previously, we have demonstrated potent hypoglycemic activity of lyophilized aqueous extract of Murraya koenigii leaves in normal and alloxan induced diabetic rabbits for short duration of 6 h. In this study, we examined the effect of 1 month oral administration of Murraya koenigii aqueous leaves extract in normal and STZ induced severe diabetic rats, at the dose of 300 mg/kg bw, on various biochemical parameters, viz., fasting blood glucose (FBG), total cholesterol (TC), HDL-cholesterol (HDL), triglyceride (TG), alkaline phosphatase (ALKP), serum glutamate oxaloacetate and pyruvate transaminases (SGOT and SGPT) and serum creatinine. In case of diabetic animals fasting blood glucose (FBG) levels of treated animals reduced by 48.2% after 30 days treatment with the aqueous leaves extract. A fall of 19.2 and 30.8% in TC and 22.97 and 37.1% in TG levels were also observed in the case of treated normal as well as diabetic rats, respectively. Feeding the extract increased the HDL-cholesterol level by 16 and 29.4% in normal and diabetic rats, respectively, as compared with their initial values. In the normal rats after 1 month of oral administration of the extract SGOT and SGPT levels were decreased by 21.7 and 25.0%. Serum alkaline phosphatase values of the treated normal animals were also reduced by 33% while negligible change was observed in the normal control animals. In the case of diabetic rats, SGOT and SGPT levels were reduced by 36.7 and 32.2%, respectively, whereas ALKP levels decreased by 39.7% after 1 month oral administration of the extract. The serum creatinine levels decrease in normal as well as in the diabetic animals by 17.75 and 18.2%, respectively, as compared to initial values. In the diabetic control animals the urinary sugar remains at +4 level but there was a decrease of 75% in urine sugar in the case of treated diabetic rats. This indicates that the aqueous extract of Murraya koenigii has favorable effect in bringing down the severity of diabetes.
机译:糖尿病常伴有脂质异常,这极大地增加了糖尿病患者的心血管发病率和死亡率。以前,我们已经证明了正常和四氧嘧啶诱导的糖尿病兔在短短6 h内,Murraya koenigii叶片的冻干水提取物的强降血糖活性。在这项研究中,我们研究了以300 mg / kg bw的剂量在正常和STZ诱导的严重糖尿病大鼠中口服1个月的Murraya koenigii水叶提取物对各种生化参数的影响,即空腹血糖( FBG),总胆固醇(TC),HDL-胆固醇(HDL),甘油三酸酯(TG),碱性磷酸酶(ALKP),谷氨酸草酰乙酸和丙酮酸转氨酶(SGOT和SGPT)以及血清肌酐。在患有糖尿病动物的情况下,用水性叶提取物处理30天后,治疗动物的血糖(FBG)水平降低了48.2%。在正常和糖尿病大鼠中,TC水平分别下降了19.2%和30.8%,TG水平分别下降了22.97%和37.1%。饲喂提取物与正常值相比,正常和糖尿病大鼠的HDL-胆固醇水平分别提高了16%和29.4%。在正常大鼠中,口服提取物1个月后,SGOT和SGPT水平分别降低了21.7%和25.0%。经治疗的正常动物的血清碱性磷酸酶值也降低了33%,而在正常对照动物中观察到的变化可忽略不计。对于糖尿病大鼠,口服提取物1个月后,SGOT和SGPT水平分别降低了36.7%和32.2%,而ALKP水平降低了39.7%。与初始值相比,正常人和糖尿病动物的血清肌酐水平分别降低了17.75%和18.2%。在糖尿病对照动物中,尿糖保持在+4水平,但是在治疗的糖尿病大鼠的情况下,尿糖减少了75%。这表明紫茉莉的水提取物对降低糖尿病的严重程度具有有利的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号